AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25257450 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II elastic group
Number of subjects: 60
Study 25257450 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 22594985 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (ALA, 630-635 nm wavelength)
Number of subjects: 85
Study 22594985 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 85
Study 20090482 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered lidocaine 1% with epinephrine
Number of subjects: 39
Study 20090482 — intervention group
Group type: COMPARATOR
Intervention: Unbuffered lidocaine 1% with epinephrine
Number of subjects: 39
Study 17396436 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification intervention (half-hour talk on exercise and diet, repeated after 3 months, weekly diaries, weekly phone calls)
Number of subjects: 27
Study 17396436 — intervention group
Group type: COMPARATOR
Intervention: Control group (initial instruction only)
Number of subjects: 27
Study 14557419 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined T(4)/T(3) treatment (liothyronine 10 micro g substituted for 50 micro g of T(4))
Number of subjects: 110
Study 14557419 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined T(4)/T(3) treatment
Number of subjects: 110
Study 14557419 — intervention group
Group type: COMPARATOR
Intervention: T(4) treatment
Number of subjects: 110
Study 14557419 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of subjects with comparable serum TSH concentrations
Number of subjects: 110
Study 10848687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrefluxing valve irrigation system
Number of subjects: 133
Study 10848687 — intervention group
Group type: COMPARATOR
Intervention: Conventional irrigation system
Number of subjects: 133
Study 9366660 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg
Number of subjects: 96
Study 9366660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 8260338 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinifloat mattress
Number of subjects: 10
Study 8260338 — intervention group
Group type: EXPERIMENTAL
Intervention: Therarest mattress
Number of subjects: 10
Study 8260338 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital mattress
Number of subjects: 10
Study 8260338 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 10
Study 8260338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 10
Study 2931515 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydioxanone suture (PDS)
Number of subjects: 100
Study 2931515 — intervention group
Group type: COMPARATOR
Intervention: Ethilon
Number of subjects: 100
Study 2931515 — intervention group
Group type: COMPARATOR
Intervention: Nurolon
Number of subjects: 100
Study 2931515 — intervention group
Group type: COMPARATOR
Intervention: Prolene
Number of subjects: 100
Study 30274925 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention menu with child-friendly labeling
Number of subjects: 163
Study 30274925 — intervention group
Group type: COMPARATOR
Intervention: Control menu layout
Number of subjects: 163
Study 28625890 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 0
Study 28625890 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 0
Study 24451659 — intervention group
Group type: EXPERIMENTAL
Intervention: Very preterm participants with no evidence for severe brain injury
Number of subjects: 0
Study 24451659 — intervention group
Group type: EXPERIMENTAL
Intervention: Very preterm participants
Number of subjects: 0
Study 24451659 — intervention group
Group type: COMPARATOR
Intervention: Term controls
Number of subjects: 0
Study 23711010 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release manipulation of the posterior knee clearance
Number of subjects: 120
Study 23711010 — intervention group
Group type: COMPARATOR
Intervention: Control group (cleaned the osteophyte of the posterior condyle only)
Number of subjects: 120
Study 21220067 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-induction condition (distressing)
Number of subjects: 95
Study 21220067 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-induction condition (neutral)
Number of subjects: 95
Study 21220067 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DSH)
Number of subjects: 95
Study 19585911 — intervention group
Group type: EXPERIMENTAL
Intervention: GuttaFlow and a single GP cone
Number of subjects: 3
Study 19585911 — intervention group
Group type: COMPARATOR
Intervention: GP using lateral condensation
Number of subjects: 3
Study 17189672 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (75mg)
Number of subjects: 8
Study 17189672 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib (40mg)
Number of subjects: 8
Study 17189672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 14996474 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic control (n=12)
Number of subjects: 19
Study 14996474 — intervention group
Group type: COMPARATOR
Intervention: No improvement in glycemic control (n=7)
Number of subjects: 19
Study 11025234 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (10 microg)
Number of subjects: 73
Study 11025234 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (30 microg)
Number of subjects: 73
Study 11025234 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (5 microg) + Clonidine (15 microg)
Number of subjects: 73
Study 11025234 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 73
Study 11025234 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 73
Study 8762789 — intervention group
Group type: EXPERIMENTAL
Intervention: One injection of penicillin G
Number of subjects: 599
Study 8762789 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V tablets for 6 days
Number of subjects: 599
Study 8762789 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 599
Study 1384364 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, modularized skills training
Number of subjects: 41
Study 1384364 — intervention group
Group type: COMPARATOR
Intervention: Supportive group psychotherapy
Number of subjects: 41
Study 2931988 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol/levonorgestrel
Number of subjects: 11
Study 2931988 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol/desogestrel
Number of subjects: 11
Study 2931988 — intervention group
Group type: COMPARATOR
Intervention: Control cycle
Number of subjects: 11
Study 31337647 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collection-based HPV DNA testing (arm A)
Number of subjects: 2356
Study 31337647 — intervention group
Group type: COMPARATOR
Intervention: Visual Inspection with Acetic Acid (VIA) screening (arm B)
Number of subjects: 2356
Study 31337647 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up for high risk HPV positive women
Number of subjects: 2356
Study 30336852 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ketamine (0.5 mg kg-1 or 1.0 mg kg-1)
Number of subjects: 670
Study 30336852 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 670
Study 30336852 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ketamine (Lo-K plus Hi-K)
Number of subjects: 670
Study 30336852 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 670
Study 27736142 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning messages during winning slot machine play
Number of subjects: 0
Study 27736142 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning messages during losing slot machine play
Number of subjects: 0
Study 27736142 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no warning messages)
Number of subjects: 0
Study 23770131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosmetic camouflage (Microskin™)
Number of subjects: 63
Study 23770131 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 63
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 0.05%
Number of subjects: 100
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 0.1%
Number of subjects: 100
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 0.2%
Number of subjects: 100
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 0.4%
Number of subjects: 100
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 0.8%
Number of subjects: 100
Study 23787820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23787820 — intervention group
Group type: EXPERIMENTAL
Intervention: K-115 (all concentrations)
Number of subjects: 100
Study 21337906 — intervention group
Group type: EXPERIMENTAL
Intervention: Local conjunctival immunotherapy (LCIT) using mixed Dermatophagoides extracts, administered as eyedrops once daily for 6 months.
Number of subjects: 18
Study 21337906 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (BSS) as a control for 6 months.
Number of subjects: 18
Study 18683852 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacopa monniera (2 x 150 mg KeenMind)
Number of subjects: 107
Study 18683852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 16437190 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 30
Study 16437190 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium, vitamin D, and sex steroids (without pamidronate)
Number of subjects: 30
Study 16437190 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 16437190 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without pamidronate
Number of subjects: 30
Study 12798977 — intervention group
Group type: EXPERIMENTAL
Intervention: D-fenfluramine (D-FEN) (0.5 mg/kg)
Number of subjects: 14
Study 12798977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11174123 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine therapy
Number of subjects: 489
Study 8868976 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (group 1, n = 22)
Number of subjects: 88
Study 8868976 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (group 2, n = 22)
Number of subjects: 88
Study 8868976 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat (group 3, n = 22)
Number of subjects: 88
Study 8868976 — intervention group
Group type: COMPARATOR
Intervention: Saline solution as placebo (control group, n = 22)
Number of subjects: 88
Study 1319808 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 65
Study 1319808 — intervention group
Group type: COMPARATOR
Intervention: Control (barbiturates or bed rest)
Number of subjects: 65
Study 31850717 — intervention group
Group type: EXPERIMENTAL
Intervention: lncRNA expression profiling in advanced resected GA tissues using a lncRNA microarray chip
Number of subjects: 47
Study 31850717 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time quantitative reverse transcription PCR (qRT-PCR) for 5 differentially expressed lncRNAs (HNF1A-AS1, RP11-62F24.2, GAS5, MALAT1, H19)
Number of subjects: 47
Study 31850717 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of nearby coding genes (mRNAs)
Number of subjects: 47
Study 31850717 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially expressed lncRNAs
Number of subjects: 47
Study 28322885 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish CavityShield (CS)
Number of subjects: 18
Study 28322885 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish Enamel Pro (EP)
Number of subjects: 18
Study 28322885 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish Vanish (V)
Number of subjects: 18
Study 28322885 — intervention group
Group type: COMPARATOR
Intervention: Comparison of fluoride varnishes
Number of subjects: 18
Study 26026919 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium exposure
Number of subjects: 1047
Study 26026919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047
Study 23356420 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 0
Study 23356420 — intervention group
Group type: COMPARATOR
Intervention: Medical Management (MM)
Number of subjects: 0
Study 21551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (target dose 10 mg o.d.)
Number of subjects: 1010
Study 21551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (target dose 10 mg b.i.d.)
Number of subjects: 1010
Study 21551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bisoprolol and enalapril
Number of subjects: 1010
Study 20684146 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% azelaic acid gel applied twice daily for one month
Number of subjects: 31
Study 20684146 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel applied twice daily for one month
Number of subjects: 31
Study 20684146 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% azelaic acid gel
Number of subjects: 31
Study 20684146 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 31
Study 16938146 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiagnosed ADHD
Number of subjects: 752
Study 16938146 — intervention group
Group type: COMPARATOR
Intervention: Non-ADHD controls
Number of subjects: 752
Study 16938146 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosed ADHD
Number of subjects: 752
Study 16359967 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg/d for the first 10 days of the cycle)
Number of subjects: 80
Study 16359967 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone plus Diane 35 (spironolactone 100 mg/d; Diane 35 is a combination tablet of 2 mg cyproterone acetate and 35 microg ethinylestradiol/d for 9 months)
Number of subjects: 80
Study 16359967 — intervention group
Group type: COMPARATOR
Intervention: Flutamide and spironolactone plus Diane 35
Number of subjects: 80
Study 12225339 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilboestrol (DES) and aspirin
Number of subjects: 28
Study 12225339 — intervention group
Group type: COMPARATOR
Intervention: Flutamide
Number of subjects: 28
Study 12225339 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilboestrol (DES)
Number of subjects: 28
Study 12225339 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilboestrol (DES) and Flutamide
Number of subjects: 28
Study 9706950 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (10 mg)
Number of subjects: 0
Study 9706950 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.3 mg)
Number of subjects: 0
Study 9706950 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (0.35 mg)
Number of subjects: 0
Study 9706950 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (20 mg)
Number of subjects: 0
Study 9706950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg)
Number of subjects: 0
Study 9706950 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Sodium Chloride (10 mL)
Number of subjects: 0
Study 7832598 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (2 g)
Number of subjects: 25
Study 7832598 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 25
Study 2226737 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-drug combination therapy
Number of subjects: 92
Study 2226737 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 92
Study 2226737 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 92
Study 2226737 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative treatment regimens
Number of subjects: 92
Study 417957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 15
Study 417957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30971600 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided IJV cannulation
Number of subjects: 100
Study 30971600 — intervention group
Group type: COMPARATOR
Intervention: US-guided axillary venous cannulation
Number of subjects: 100
Study 27607850 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated recall cards and medication chart checking at handover
Number of subjects: 534
Study 27607850 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 534
Study 24784976 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month LNS supplementation
Number of subjects: 29
Study 24784976 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month LNS supplementation
Number of subjects: 29
Study 24784976 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 23111657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous peramivir 400 mg once daily
Number of subjects: 137
Study 23111657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous peramivir 200 mg once daily
Number of subjects: 137
Study 23111657 — intervention group
Group type: COMPARATOR
Intervention: Oral oseltamivir 75 mg twice daily
Number of subjects: 137
Study 23111657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous peramivir 400 mg once daily (in clinically unstable patients)
Number of subjects: 137
Study 23111657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous peramivir 200 mg once daily (in clinically unstable patients)
Number of subjects: 137
Study 23111657 — intervention group
Group type: COMPARATOR
Intervention: Oral oseltamivir 75 mg twice daily (in clinically unstable patients)
Number of subjects: 137
Study 21501161 — intervention group
Group type: EXPERIMENTAL
Intervention: rGH treatment in Group A (n = 8)
Number of subjects: 20
Study 21501161 — intervention group
Group type: COMPARATOR
Intervention: rGH treatment in Group B (n = 5)
Number of subjects: 20
Study 21501161 — intervention group
Group type: COMPARATOR
Intervention: Vaccination alone in Group C (n = 7)
Number of subjects: 20
Study 21501161 — intervention group
Group type: EXPERIMENTAL
Intervention: rGH treatment in Groups A (n = 8) and B (n = 5) combined
Number of subjects: 20
Study 21501161 — intervention group
Group type: COMPARATOR
Intervention: Vaccination alone in Group C (n = 6)
Number of subjects: 20
Study 19700872 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% tropicamide and 2.5% phenylephrine mixture
Number of subjects: 40
Study 19700872 — intervention group
Group type: COMPARATOR
Intervention: 1% tropicamide and 10% phenylephrine (alternate application)
Number of subjects: 40
Study 16722923 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based programme on the management of low back pain, including advice on increasing activity levels and challenging patients' fears and beliefs about their pain.
Number of subjects: 30
Study 16722923 — intervention group
Group type: COMPARATOR
Intervention: Standard in-service training package on the management of common knee pathologies.
Number of subjects: 30
Study 15319705 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.2 mg/kg IV bolus)
Number of subjects: 44
Study 15319705 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Intralipid, Kabi Pharmacia)
Number of subjects: 44
Study 10981746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative mild hypothermia (33.5 degrees C, n = 12)
Number of subjects: 24
Study 10981746 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (37 degrees C, n = 12)
Number of subjects: 24
Study 9432343 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 3 gm/day and lansoprazole (30-180 mg/day) for 2 weeks
Number of subjects: 36
Study 8342972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C alone
Number of subjects: 66
Study 8342972 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C and alternating BCG therapy
Number of subjects: 66
Study 3521480 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimantadine treatment (200 mg/day for 5 days)
Number of subjects: 0
Study 29670285 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic preservation
Number of subjects: 220
Study 29670285 — intervention group
Group type: COMPARATOR
Intervention: Conventional static cold storage
Number of subjects: 220
Study 27185702 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training
Number of subjects: 54
Study 27185702 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel phantom training
Number of subjects: 54
Study 27185702 — intervention group
Group type: COMPARATOR
Intervention: Standard medical knowledge (Control)
Number of subjects: 54
Study 24860180 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol (measured directly)
Number of subjects: 23738
Study 24860180 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of LDL particles
Number of subjects: 23738
Study 24860180 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-density lipoprotein particles
Number of subjects: 23738
Study 24860180 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of cholesterol-poor small LDL
Number of subjects: 23738
Study 24860180 — intervention group
Group type: EXPERIMENTAL
Intervention: Small very-low-density lipoprotein particles
Number of subjects: 23738
Study 24860180 — intervention group
Group type: COMPARATOR
Intervention: Larger cholesterol-rich LDL particles
Number of subjects: 23738
Study 24860180 — intervention group
Group type: COMPARATOR
Intervention: All high-density lipoprotein measures
Number of subjects: 23738
Study 22427342 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphical display decision support system (Navigator™)
Number of subjects: 0
Study 22427342 — intervention group
Group type: COMPARATOR
Intervention: Numerical guidance (control)
Number of subjects: 0
Study 19897672 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon stimulation test
Number of subjects: 138
Study 19001601 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of elemental calcium with 400 IU of vitamin D(3) daily
Number of subjects: 36282
Study 19001601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study 19001601 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 36282